Evaluation of 9 biomarkers for predicting 10-year cardiovascular risk in patients undergoing coronary angiography: findings from the LUdwigshafen RIsk and Cardiovascular Health (LURIC) study.

[1]  W. März,et al.  Vitamin D Levels Predict All-Cause and Cardiovascular Disease Mortality in Subjects With the Metabolic Syndrome , 2012, Diabetes Care.

[2]  D. J. Veldhuisen,et al.  Vitamin D status and outcomes in heart failure patients , 2011, European journal of heart failure.

[3]  J. Kaski,et al.  A comparative study of biomarkers for risk prediction in acute coronary syndrome-Results of the SIESTA (Systemic Inflammation Evaluation in non-ST-elevation Acute coronary syndrome) study. , 2010, Atherosclerosis.

[4]  V. Salomaa,et al.  Contribution of 30 Biomarkers to 10-Year Cardiovascular Risk Estimation in 2 Population Cohorts: The MONICA, Risk, Genetics, Archiving, and Monograph (MORGAM) Biomarker Project , 2010, Circulation.

[5]  Jennifer G. Robinson,et al.  Multimarker prediction of coronary heart disease risk: the Women's Health Initiative. , 2010, Journal of the American College of Cardiology.

[6]  Nancy R Cook,et al.  Advances in Measuring the Effect of Individual Predictors of Cardiovascular Risk: The Role of Reclassification Measures , 2009, Annals of Internal Medicine.

[7]  E. Zakynthinos,et al.  Inflammatory biomarkers in coronary artery disease. , 2009, Journal of cardiology.

[8]  F. Harrell,et al.  Criteria for Evaluation of Novel Markers of Cardiovascular Risk: A Scientific Statement From the American Heart Association , 2009, Circulation.

[9]  P. Libby,et al.  The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models , 2008, Nature Reviews Immunology.

[10]  W. März,et al.  Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. , 2008, The Journal of clinical endocrinology and metabolism.

[11]  B. Boehm,et al.  Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. , 2008, Archives of internal medicine.

[12]  Anders Larsson,et al.  Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. , 2008, The New England journal of medicine.

[13]  B. Jilma,et al.  Von Willebrand Factor in Cardiovascular Disease: Focus on Acute Coronary Syndromes , 2008, Circulation.

[14]  S. Sevimli,et al.  Comparison of serum levels of inflammatory markers and allelic variant of interleukin-6 in patients with acute coronary syndrome and stable angina pectoris , 2008, Coronary artery disease.

[15]  M. Sata,et al.  Open sesame! CXCR4 blockade recruits neutrophils into the plaque. , 2008, Circulation research.

[16]  F. Tacke,et al.  Protective Role of CXC Receptor 4/CXC Ligand 12 Unveils the Importance of Neutrophils in Atherosclerosis , 2008, Circulation research.

[17]  M. Pencina,et al.  Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond , 2008, Statistics in medicine.

[18]  N. Bodyak,et al.  Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals , 2007, Proceedings of the National Academy of Sciences.

[19]  D. Tishkoff,et al.  1,25(OH)2-vitamin D3 actions on cell proliferation, size, gene expression, and receptor localization, in the HL-1 cardiac myocyte , 2007, The Journal of Steroid Biochemistry and Molecular Biology.

[20]  D. Levy,et al.  Multiple biomarkers for the prediction of first major cardiovascular events and death. , 2006, The New England journal of medicine.

[21]  M. Pencina,et al.  C-reactive protein and risk of cardiovascular disease in men and women from the Framingham Heart Study. , 2005, Archives of internal medicine.

[22]  P. Greenland,et al.  When is a new prediction marker useful? A consideration of lipoprotein-associated phospholipase A2 and C-reactive protein for stroke risk. , 2005, Archives of internal medicine.

[23]  B. Horne,et al.  Which white blood cell subtypes predict increased cardiovascular risk? , 2005, Journal of the American College of Cardiology.

[24]  Rodney X. Sturdivant,et al.  Applied Logistic Regression: Hosmer/Applied Logistic Regression , 2005 .

[25]  Imran Awan,et al.  Leukocyte count and coronary heart disease: implications for risk assessment. , 2004, Journal of the American College of Cardiology.

[26]  Vilmundur Gudnason,et al.  C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. , 2004, The New England journal of medicine.

[27]  A. Tall.  C-reactive protein reassessed. , 2004, The New England journal of medicine.

[28]  A. Siegbahn,et al.  Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy. , 2001, JAMA.

[29]  W. März,et al.  Rationale and design of the LURIC study--a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease. , 2001, Pharmacogenomics.

[30]  H. Drexler,et al.  Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability. , 2000, Circulation.

[31]  S. Thompson,et al.  Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. , 1995, The New England journal of medicine.

[32]  J. Jansson,et al.  von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death. , 1991, British heart journal.

[33]  G. W. Snedecor.  STATISTICAL METHODS , 1967 .

[34]  N. Unwin,et al.  Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .

[35]  W. Markiewicz,et al.  Predictive value of white blood cell subtypes for long-term outcome following myocardial infarction. , 2008, Atherosclerosis.

[36]  A. Lazzarin,et al.  Interleukin-6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line. , 1998, Blood.

[37]  T. Schall,et al.  Local expression of inflammatory cytokines in human atherosclerotic plaques. , 1994, Journal of atherosclerosis and thrombosis.

[38]  M. Brennan,et al.  Follow-up [2] , 1992 .